Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lesniak

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Expert Review of Neurotherapeutics|April 21, 2006
Gene therapy for malignant gliomaMaciej S Lesniak
Technology in Cancer Research & Treatment|July 21, 2005
Novel advances in drug delivery to brain cancerMaciej S Lesniak
Expert Opinion on Biological Therapy|May 22, 2009
Adenoviral virotherapy for malignant brain tumorsSuvobroto Nandi, Maciej S Lesniak
Current Drug Delivery|April 26, 2007
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumorsSherise Ferguson, Maciej S Lesniak
Neurosurgical Focus|April 23, 2005
Percival Bailey and the classification of brain tumorsSherise Ferguson, Maciej S Lesniak
Journal of Extracellular Biology|May 7, 2025
Role of Extracellular Vesicles in the Pathogenesis of Brain MetastasisMuhammad Izhar, Maciej S Lesniak
Journal of Neuro-Oncology|January 12, 2007
CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomasAbdeljabar El Andaloussi, Maciej S Lesniak
Neuro-Oncology|May 26, 2006
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiformeAbdeljabar El Andaloussi, Maciej S Lesniak
Oncoimmunology|July 25, 2014
Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant gliomaDerek A Wainwright, Maciej S Lesniak
Expert Review of Neurotherapeutics|November 9, 2005
Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletionsAdam M Sonabend, Maciej S Lesniak
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Expert Review of Neurotherapeutics|April 21, 2006
Gene therapy for malignant gliomaMaciej S Lesniak
Technology in Cancer Research & Treatment|July 21, 2005
Novel advances in drug delivery to brain cancerMaciej S Lesniak
Expert Opinion on Biological Therapy|May 22, 2009
Adenoviral virotherapy for malignant brain tumorsSuvobroto Nandi, Maciej S Lesniak
Current Drug Delivery|April 26, 2007
Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumorsSherise Ferguson, Maciej S Lesniak
Neurosurgical Focus|April 23, 2005
Percival Bailey and the classification of brain tumorsSherise Ferguson, Maciej S Lesniak
Journal of Extracellular Biology|May 7, 2025
Role of Extracellular Vesicles in the Pathogenesis of Brain MetastasisMuhammad Izhar, Maciej S Lesniak
Journal of Neuro-Oncology|January 12, 2007
CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomasAbdeljabar El Andaloussi, Maciej S Lesniak
Neuro-Oncology|May 26, 2006
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiformeAbdeljabar El Andaloussi, Maciej S Lesniak
Oncoimmunology|July 25, 2014
Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant gliomaDerek A Wainwright, Maciej S Lesniak
Expert Review of Neurotherapeutics|November 9, 2005
Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletionsAdam M Sonabend, Maciej S Lesniak
Pageof 28